Naproxen May Be “Exception” To NSAID Rule, But Data Is Lacking – FDA
This article was originally published in The Tan Sheet
Executive Summary
An FDA memorandum released April 15 points to naproxen as a potentially safer NSAID compared to other drugs in the class